Skip to main content

Hepatitis Management Programme


Young woman looking into the distance


In 2023, it is estimated that approximately 410,000 individuals were living with chronic hepatitis B in Hong Kong, which might increase their risk of progressing to liver diseases such as cirrhosis and liver cancer if left unmanaged1. The ‘Hepatitis Management Programme’ (Programme) at CUHK Medical Centre, which includes the Hepatitis Screening Programme and the Hepatitis B Management Programme, is designed to offer patients the early detection, monitoring, and personalised care for hepatitis infections, particularly, chronic hepatitis B.
 

Potential threats of Hepatitis A, B, and C 

HAV icon  

Hepatitis A virus (HAV)

Hepatitis A virus (HAV) is primarily spread through the “faecal-oral” route, where individuals having contact with contaminated objects (for example, shellfish or water tainted by the virus). Most people fully recover with lifelong immunity, but a small fraction of the infected people may face fatal complications, such as fulminant hepatitis (acute liver failure).
 

HBV icon  

Hepatitis B virus (HBV)

Hepatitis B virus (HBV) is spread through contact with blood or body fluids of an infected person (such as blood contact via contaminated items or needles), mother-to-infant transmission during delivery, and sexual contact.

  • According to the Population Health Survey 2020–22 conducted by the Department of Health, about 40% of those tested positive for hepatitis B surface antigen are unaware of their condition, and about 70% of them lack medical follow-up1.
  • Chronic Hepatitis B (CHB) is a lifelong infection. Without treatment, CHB may lead to severe liver issues such as cirrhosis and liver cancer.
     

HCV icon  

Hepatitis C virus (HCV)

Hepatitis C virus (HCV) is mostly spread through infected blood or body fluids and can cause both acute and chronic hepatitis. In 2023, it is estimated that around 17,000 individuals had hepatitis C in Hong Kong1. Around 70% of those infected with HCV will develop chronic HCV infection which may lead to cirrhosis and liver cancer.

 

 

Hepatitis A, B, and C have similar symptoms yet varying incubation periods, and they require blood tests for accurate diagnosis. Early diagnosis, treatment, and adequate management are crucial to prevent severe complications.

1
Viral Hepatitis Control Office, Department of Health, The Government of the Hong Kong Special Administrative Region.  Thematic Report on Viral Hepatitis (Population Health Survey 2020-22). Retrieved 6 March 2025. https://www.hepatitis.gov.hk/english/health_professionals/thematic_report_on_viral_hepatitis.html

Symptoms of Hepatitis B

Most patients with hepatitis B are asymptomatic. For those who develop symptoms, they typically appear gradually after an incubation period of 30 days to 180 days. Common signs are often vague, such as fever, fatigue, loss of appetite, nausea, vomiting, upper abdominal discomfort, tea-coloured urine and jaundice (yellowing of the skin and the whites of eyes).

Programme Features
 

Image of a woman in her 30s

Screening

Get tested for hepatitis to check whether you have been infected.

 
 

Image of an expectant mother with ultrasound of her baby

Awareness and Action

Individuals who are identified as uninfected and lacking hepatitis antibodies through screening can choose to receive vaccinations* to prevent hepatitis. 


* Vaccination is an optional item that will be charged separately.

 
 

Image of an expectant mother with ultrasound of her baby

Hepatitis B Management

Provide doctor consultation and further screening to individuals who are tested positive for hepatitis B to enable early detection and monitoring of complications from chronic hepatitis B, such as cirrhosis and liver cancer.
 


Programme Details and Fee

Hepatitis Screening Programme

Young woman looking into the distance

Testing for Hepatitis A, B, and liver function to detect infections early, assess liver health, and guide preventive care are critical for avoiding serious complications like cirrhosis or liver cancer.

Book Now

   

 

 Hepatitis Screening Programme
  Investigation Items  Objectives
 Have you had a Liver Function Test in the last 6 months?
NOYES
 Doctor Consultation &
Report Analysis

 

  • Pre-test consultation & report analysis by doctor
 Hepatitis A Screening
 
 
Hepatitis A virus-specific Immunoglobulin M (IgM) antibodies

 

  • To determine the presence of Hepatitis A antibody
 Hepatitis B Screening
 
HBsAg 
(Hepatitis B surface antigen)

 

  • To determine the status of Hepatitis B infection
 anti-HBs 
(Hepatitis B surface antibody)

 

  • To determine if there is sufficient
    Hepatitis B antibody
 HBcAb 
(Hepatitis B core antibody)

 

  • To determine history of Hepatitis B infection
 Liver Function Test
 
 

- Total Protein, Albumin, Globulin
 
- ALT
 
- Gamma GT(γ-GT)
 
- Alkaline Phosphatase
 
- AST
 
- Total Bilirubin
 

 

  • To assess liver health issues such as hepatitis, cirrhosis, or metabolic dysfunction–associated steatotic liver disease
  
  
  
 
 
Discounted Fee (HKD) $ 2,100$ 1,800
Original Fee (HKD) $ 4,070$ 3,440

Add-on Hepatitis C Screening test is available under the ‘Health Plus’ Check-up Scheme set out below. 

Click to Learn More

Icon on a pregnant woman

 

Hepatitis B Management Programme

Young woman looking into the distance

Chronic Hepatitis B patient should receive regular medical assessment. This Hepatitis B Management Programme provides essential follow-up doctor consultation and screening to monitor disease progression and complications.

This programme is designed for:

  • Individuals who tested positive for Hepatitis B during screening
  • People diagnosed with Chronic Hepatitis B (CHB)
  • Patients at risk of liver complications due to Hepatitis B 

Book Now

 

 

 Hepatitis B Management Programme
  Investigation Items  Objectives
 Have you had a Liver Function Test 
in the last 6 months?
NOYES
 Doctor Consultation &
Report Analysis

 

  • Pre-test consultation & report analysis by doctor
      Hepatocellular Carcinoma (HCC) Surveillance
 
Alpha Fetoprotein (AFP) 

 

  • To assess the risk of liver cancer
 
 Liver Ultrasound

 

  • Detect the presence of liver tumours 
     Liver Function Test
 
 

- Total Protein, Albumin, Globulin
 
- ALT
 
- Gamma GT(γ-GT)
 
- Alkaline Phosphatase
 
- AST
 
- Total Bilirubin
  

 

  • To assess liver health issues such as hepatitis, cirrhosis, or metabolic dysfunction–associated steatotic liver disease
 
 
Discounted Fee (HKD) $ 2,680$ 2,380
Original Fee (HKD) $ 3,540$ 2,910

‘Health Plus’ Check-up Scheme

Young woman looking into the distance
Investigation Items

FibroScan 

Measures liver stiffness (for fibrosis) and Controlled Attenuation Parameter (CAP) for liver fat

Antibody against Hepatitis C Virus (Anti-HCV)

To determine whether a person has past exposure to HCV

HBeAg

Monitoring phases of chronic Hepatitis B virus infection

Anti-HBe

Monitoring phases of chronic Hepatitis B virus infection

 

Service Hours

  • MON - FRI:
    9:00AM - 5:00PM

    SAT:
    9:00AM - 1:00PM

    SUN AND PUBLIC HOLIDAYS:
    CLOSED

Booking and enquiry

 

Important Notes 

Young woman looking into the distance

  1. The Programme aims to provide health monitoring and guidance for individuals at risk of or being affected by hepatitis.
  2. Advance booking is required for the Programme.
  3. Avoid staying up late, drinking, or strenuous exercising the day before your check-up.
  4. Please notify the doctor of any medication that you are currently using, especially medication used on long-term basis for diseases such as hypertension, diabetes, and/or cardiovascular diseases, before performing any test.
  5. Please notify the medical team prior to any blood draw if you have blood or needle phobia or have any bleeding disorders or are taking anticoagulants (Such as Warfarin, NOACs, etc.).
  6. Please follow instructions from the medical team during your check-up. If you experience any discomfort, notify the team immediately.
  7. Participants are responsible for any costs associated with additional tests, vaccinations, and/or medical consultation beyond the service scope of the relevant programme. 
  8. If the doctor determines that a participant is not suitable to receive the services under the relevant programme, or the relevant programme is not applicable to the participant, CUHK Medical Centre will only charge doctor consultation fee and (if applicable) any related diagnostic and/or medication fees/charges according to its/their prevailing prices.
  9. All items in the Programme are fixed. If, for whatever reason, a participant is unable to complete all the items under the relevant programme, there will be no refund or exchange for items not completed. 
  10. Unless otherwise specified by CUHK Medical Centre, any offer (such as the Discounted Fee) under the Programme cannot be used in conjunction with other offers or discounts.
  11. Any offer under the Programme is not transferable and cannot be exchanged for cash or other products or services, and any fees paid for the services under the Programme are not refundable and cannot be exchanged for other products or services.
  12. In case of any dispute, the decision of CUHK Medical Centre Limited shall be final and conclusive. 
     

Image of CUHKMC Wellness Centre

Related Service

Wellness Centre

Learn More